• Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter

      Nicholas inks drug supply deal with foreign firm

      Posted AtDNAIndia.com

      Nicholas Piramal Ltd, India's sixth-biggest drugmaker by market value, agreed to supply medicines to an unidentified "global hospital products company" for 10 years.

      Such deals, also called "custom manufacturing", are normally confidential in nature, and a slew of them have been struck between Indian pharma firms and multinationals that are trying to cut costs.

      Nicholas expects initial sales from the products to be between $12 million and $15 million a year. The revenues are expected to kick in from the middle of 2007. Sales from the company's so-called contract manufacturing business will account for 50% of total revenue by 2010, chairman Ajay Piramal said in a September interview.

      The agreement with the hospital company can be extended annually after 10 years, and can be expanded to include additional drugs.

      Nicholas already has agreements to supply health-care products to companies including Irvine, California-based Allergan Inc and Santa Ana, California-based Advanced Medical Optics Inc.

      After its second-quarter results, the company had said it expected to sign five such deals before December end. With Thursday's announcement, Nicholas has now signed two deals in two months. The first was with AstraZeneca in late October, under which it will develop active pharmaceutical ingredients used to make medicines.

      Under custom manufacturing, the whole process from development to commercialisation of a drug is customised according to the client's needs.

      Whereas in contract manufacturing, only the job to produce an active pharma ingredient is farmed out.

      In terms of revenue, custom manufacturing is lucrative, affording 20-25% margins. Apart from Nicholas, Hyderabad-based Dr Reddy's Laboratories, and the New Delhi-based Ind Swift Laboratories are some of the companies following the path.

      The advantage of this strategy is that revenue is assured, and the legal hassles that follow moves to produce patented drugs are avoided.

      November 25, 2005


      Share this Article!

    Back to top^